The Masked Intruder: Rasburicase Unveiling Methemoglobinemia in Tumor Lysis Syndrome

被引：0
|
作者：
Peshin, Supriya [1 ]
Singal, Sakshi [2 ]
机构：
[1] Norton Community Hosp, Norton, MA USA
[2] East Tennessee State Univ, Johnson City, TN USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
case; b-cell lymphoma; methemoglobinemia; tumor lysis syndrome;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IBCL-802
引用
收藏
页码：S509 / S509
页数：1
相关论文
共 50 条
  • [41] Professional practice evaluation of uses of rasburicase in tumor lysis syndrome in a French University Hospital
    Annereau, M.
    Fouche, C.
    Smulevici, A.
    Joly, A. C.
    Vekhoff, A.
    Isnard, F.
    Legrand, O.
    Tilleul, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 223 - 224
  • [42] A single 6 milligram dose of rasburicase for the management of tumor lysis syndrome in adults.
    McDonnell, A
    Hall, PD
    Lenz, K
    Hayslip, R
    Frei-Lahr, D
    PHARMACOTHERAPY, 2005, 25 (10): : 1470 - 1470
  • [43] Efficacy of single dose rasburicase in prophylaxis and treatment of tumor lysis syndrome: a metaanalysis.
    Feng, Xiaodong
    Dong, Kevin
    Dan Pham
    Inciardi, John
    Bhutada, Nilesh
    PHARMACOTHERAPY, 2012, 32 (10): : E222 - E222
  • [44] COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGY
    Rodrigues, A. H.
    Follador, W.
    Abadi, M.
    Petrilli, A. S.
    VALUE IN HEALTH, 2011, 14 (03) : A166 - A166
  • [45] EFFICACY OF RASBURICASE FOR THE PROPHYLAXIS OF TUMOR LYSIS SYNDROME IN NON-HODGKIN LYMPHOMA PATIENTS
    Takahashi, Hiroyuki
    Takasaki, Hirotaka
    Ishiyama, Yasufumi
    Nakazono, Ayano
    Hattori, Yukako
    Watanabe, Reina
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    Sakai, Rika
    ANNALS OF ONCOLOGY, 2014, 25
  • [46] Efficacy of Single Dose Rasburicase (1.5 MG) for Prophylaxis and Management of Tumor Lysis Syndrome
    Radhakrishnan, V.
    Philips, A.
    Ramamoorthy, J.
    Ganesan, P.
    Sagar, T.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S533 - S534
  • [47] Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults
    McDonnell, AM
    Lenz, KL
    Frei-Lahr, DA
    Hayslip, J
    Hall, PD
    PHARMACOTHERAPY, 2006, 26 (06): : 806 - 812
  • [48] PREVENTION OF THE TUMOR LYSIS-ASSOCIATED HYPERURICEMIA BY RASBURICASE
    Takaiwa, N.
    Obara, N.
    Kurita, N.
    Sakata, M.
    Nishikii, H.
    Yokoyama, Y.
    Suzukawa, K.
    Hasegawa, Y.
    Chiba, S.
    ANNALS OF ONCOLOGY, 2013, 24
  • [49] Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome
    Ashwin Philips
    Venkatraman Radhakrishnan
    Prasanth Ganesan
    T. S. Ganesan
    Jaikumar Ramamurthy
    Manikandan Dhanushkodi
    T. G. Sagar
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 618 - 622
  • [50] A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults
    Giraldez, Miriam
    Puto, Katarzyna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (02) : 177 - 179
12345